Professional
Added to YB: 2024-07-31
Pitch date: 2024-06-30
BIO [bullish]
Bio-Rad Laboratories, Inc.
-0.65%
current return
Author Info
No bio for this author
Company Info
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Market Cap
$6.9B
Pitch Price
$273.68
Price Target
N/A
Dividend
N/A
EV/EBITDA
11.98
P/E
9.21
EV/Sales
2.62
Sector
Life Sciences Tools and Services
Category
value
Longleaf Partners Fund Portfolio Holding: Bio-Rad Laboratories, Inc.
BIO: Life sciences co. underperforming due to delayed growth. Strong balance sheet for share buybacks. Margins below peers suggest improvement potential. Undervalued Sartorius stake. Anticipate solid growth return, sooner than market expects. Peers priced for growth despite tough industry environment. No new competitive threats since position established.
Read full article (1 min)